J&J Medical Connect
Immunology
Immunology

Congress Materials – Dermatology Education Foundation for Nurse Practitioners and Physician's Assistants (DEF NP_PA 2026)

This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.

APEX: Guselkumab Response and Inhibition of Structural Damage Progression in Active Psoriatic Arthritis by Participant Baseline Characteristics

Philip J Mease, Christopher T Ritchlin, Laura C Coates, Alexa P Kollmeier, Bei Zhou, Yusang Jiang, April W. Armstrong, Karissa Lozenski, Soumya D. Chakravarty, Proton Rahman


This document will be available after July 22nd 2026

Real-World Characterization of Patients Initiating Advanced Therapies for Moderate-to-Severe Psoriasis

Hsien-yen Chang, Chang Xu, Alexander Litvintchouk, Christopher Russo, Steve Feldman, Timothy Fitzgerald


This document will be available after July 22nd 2026

Treatment of Plaque Psoriasis Involving High-Impact Sites With Icotrokinra, a Targeted Oral Peptide: Pooled Analyses of 4 Phase 3 Placebo-Controlled Trials

Jennifer Soung, April W. Armstrong, Ronald B. Vender, Josep Riera-Monroig, Michael Sebastian, Ofelia Reyes-Servin, Bassey Effiom Edem, Ming-Chun Hsu, Shu Li, Ya-Wen Yang, Linda Stein Gold


This document will be available after July 22nd 2026

 

Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.

Would you like to clear and leave your conversation? Message history will be lost.